CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Brain Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This Brain Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…

    May 3, 2022| CRI Staff
  • Overcoming Immune Dysfunction in Brain Cancer with CRI Lloyd J. Old STAR Peter Fecci

    CRI Arash Ferdowsi Lloyd J. Old STAR Peter Fecci is seeking to characterize and develop ways to…

    February 14, 2022| Arthur N. Brodsky, PhD
  • Brain Tumor Awareness Month: 2021 Immunotherapy Research Updates

    This May for Brain Tumor Awareness Month, we look at new research, new treatments, and how we’re…

    May 5, 2021| CRI Staff
  • Brain Tumor Awareness Month: 2020 Immunotherapy Research Update

    Dr. David Reardon on cancer immunotherapy breakthroughs; what's new clinical trials; new scientific research; and how CRI…

    May 13, 2020| CRI Staff
  • AACR17 Update: Taking Immunotherapy to the Next Level

    After cancer immunotherapy’s initial successes, new challenges are being confronted

    April 1, 2017| Arthur N. Brodsky, PhD
  • Brad Silver

    Brad Silver’s Immunotherapy Story

    Brain Cancer |  Diagnosed 2003 What I loved is that there were no weird foreign medicines in it….
    March 15, 2017| CRI Staff
  • Jeannine Walston

    Jeannine Walston’s Immunotherapy Story

    Brain Cancer |  Diagnosed 1998 I absolutely know that further improved quality of life, enhanced survival, and cures…
    March 15, 2017| CRI Staff

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute